238 related articles for article (PubMed ID: 8887915)
21. Pathologic changes following transurethral canine prostatectomy with a cylindrically diffusing fiber.
Cromeens DM; Price RE; Johnson DE
Lasers Surg Med; 1994; 14(4):306-13. PubMed ID: 8078381
[TBL] [Abstract][Full Text] [Related]
22. [A basic study of the interstitial laser prostatectomy using pulsed holmium: yttrium-aluminum-garnet (Ho:YAG) laser].
Daidoh Y
Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):650-9. PubMed ID: 8709441
[TBL] [Abstract][Full Text] [Related]
23. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia.
Ruszat R; Seitz M; Wyler SF; Müller G; Rieken M; Bonkat G; Gasser TC; Reich O; Bachmann A
BJU Int; 2009 Sep; 104(6):820-5. PubMed ID: 19239441
[TBL] [Abstract][Full Text] [Related]
24. Alteration of laser-tissue interaction with the 805 nm diode laser using indocyanine green in the canine prostate.
Razvi HA; Muschter R; Anson K; Vargas JC; Perlmutter AP
Lasers Surg Med; 1996; 19(2):184-9. PubMed ID: 8887922
[TBL] [Abstract][Full Text] [Related]
25. In vitro investigation of wavelength-dependent tissue ablation: laser prostatectomy between 532 nm and 2.01 microm.
Kang HW; Kim J; Peng YS
Lasers Surg Med; 2010 Mar; 42(3):237-44. PubMed ID: 20333741
[TBL] [Abstract][Full Text] [Related]
26. [Laser treatment of benign prostatic hypertrophy: the correlation of histologic results to nuclear magnetic resonance imaging].
Sulser T; Jochum W; Huch Böni RA; Briner J; Krestin GP; Hauri D
Ann Urol (Paris); 1997; 31(1):19-26. PubMed ID: 9157818
[TBL] [Abstract][Full Text] [Related]
27. [Laser thermocoagulation of adenoma of the prostate using an interstitial approach].
Muschter R; Hofstetter A
Ann Urol (Paris); 1997; 31(1):27-37. PubMed ID: 9157819
[TBL] [Abstract][Full Text] [Related]
28. High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers.
Kuntzman RS; Malek RS; Barrett DM; Bostwick DG
Urology; 1997 May; 49(5):703-8. PubMed ID: 9145974
[TBL] [Abstract][Full Text] [Related]
29. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH).
Kuntz RM
Eur Urol; 2006 Jun; 49(6):961-9. PubMed ID: 16632179
[TBL] [Abstract][Full Text] [Related]
30. Optical characterization and coagulation performance of side-emitting fiber delivery systems for laser therapy of benign prostatic hyperplasia: a comparative study.
Protsenko D; Torres JH; Chakrabarti P; Bell B; Orihuela E; Motamedi M
Urology; 1996 Jun; 47(6):845-51. PubMed ID: 8677575
[TBL] [Abstract][Full Text] [Related]
31. A non-randomized comparative study of visual laser ablation and transurethral resection of the prostate in benign prostatic hyperplasia.
Uchida T; Egawa S; Iwamura M; Ohori M; Yokoyama E; Endo T; Koshiba K
Int J Urol; 1996 Mar; 3(2):108-12. PubMed ID: 8689503
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic laser ablation of the prostate. A new technique for treating prostate problems.
Bailey MJ
Br J Theatre Nurs; 1994 Mar; 3(12):10, 12-3. PubMed ID: 7543310
[TBL] [Abstract][Full Text] [Related]
33. Transurethral visual laser ablation of the prostate for benign prostatic hyperplasia using a KTP/YAG laser.
Miki T; Kojima Y; Nonomura N; Matsumiya K; Kokado Y; Yoshioka T; Takahara S; Okuyama A
Int J Urol; 1997 Nov; 4(6):576-9. PubMed ID: 9477187
[TBL] [Abstract][Full Text] [Related]
34. Nd:YAG laser transurethral evaporation of the prostate (TUEP) for urinary retention.
Fournier GR; Tewari A; Induhara R; Gajenderan V; Narayan P
Lasers Surg Med; 1996; 19(4):480-6. PubMed ID: 8983010
[TBL] [Abstract][Full Text] [Related]
35. High-power laser vaporization of the canine prostate using a 110 W Thulium fiber laser at 1.91 microm.
Fried NM
Lasers Surg Med; 2005 Jan; 36(1):52-6. PubMed ID: 15662624
[TBL] [Abstract][Full Text] [Related]
36. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.
Schatzl G; Madersbacher S; Lang T; Marberger M
J Urol; 1997 Jul; 158(1):105-10; discussion 110-1. PubMed ID: 9186334
[TBL] [Abstract][Full Text] [Related]
37. Laboratory parameters following contact laser ablation of the prostate for benign prostatic hypertrophy.
Gomella LG; Lotfi MA; Reagan GN
Tech Urol; 1995; 1(3):168-71. PubMed ID: 9118387
[TBL] [Abstract][Full Text] [Related]
38. Holmium:yttrium-aluminum-garnet laser prostatectomy.
Kabalin JN; Gilling PJ; Fraundorfer MR
Mayo Clin Proc; 1998 Aug; 73(8):792-7. PubMed ID: 9703310
[TBL] [Abstract][Full Text] [Related]
39. Optimization of laser prostatectomy.
van Swol CF; Verdaasdonk RM; Mooibroek J; Boon TA
Prog Clin Biol Res; 1994; 386():511-9. PubMed ID: 7528422
[TBL] [Abstract][Full Text] [Related]
40. Prospective multicenter ProLase II clinical trial of neodymium:yttrium-aluminum-garnet laser prostatectomy.
Kabalin JN; Gill HS; Leach GE; Bowers GW; Nill T; Konowalchuk TW
Urology; 1997 Jul; 50(1):63-5. PubMed ID: 9218020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
